Drug
Semaglutide Pen
Semaglutide Pen is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed133%
not_yet_recruiting267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_4
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
NCT07017270
not_yet_recruitingphase_3
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
NCT06616961
completedphase_4
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
NCT03724981
Clinical Trials (3)
Showing 3 of 3 trials
NCT07017270Phase 4
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
NCT06616961Phase 3
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
NCT03724981Phase 4
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3